Literature DB >> 30101086

Supplementing five-point body condition score with body fat percentage increases the sensitivity for assessing overweight status of small to medium sized dogs.

Gebin Li1, Peter Lee1, Nobuko Mori1, Ichiro Yamamoto1, Koh Kawasumi1, Hisao Tanabe2, Toshiro Arai1.   

Abstract

BACKGROUND AND METHODS: Currently, five-point body condition scoring (BCS) is widely used by veterinarians and clinicians to assess adiposity in dogs in Japan. However, BCS score assignment is subjective in nature, and most clinicians do not score with half points, instead preferring to round off values, thereby rendering less accurate assessments. Therefore, we sought to determine whether assessing body fat percentage using simple morphometric measurements and supplementing this with five-point BCS can have increased sensitivity for detecting increasing adiposity in overweight small-medium sized dog breeds via plasma metabolite validation.
RESULTS: Overall, lean body fat percentage was determined to be 15%-22% for male (non-neutered/neutered) dogs and 15%-25% for female (nonspayed/spayed). Dogs categorized as overweight by BCS had significantly higher levels of nonesterified fatty acids (P = 0.005), whereas animals categorized as overweight by BCS + body fat percentage were observed to have significantly higher levels of nonesterified fatty acids (P = 0.006), total cholesterol (P = 0.029), and triglycerides (P = 0.001) than lean animals. The increased sensitivity due to body fat percentage for gauging alterations in plasma metabolite levels may be due to increased correlation strength. Body fat percentage correlated positively with plasma insulin (r = 0.627, P = 0.002), nonesterified fatty acids (r = 0.674, P < 0.001), total cholesterol (r = 0.825, P < 0.0001), triglycerides (r = 0.5823, P < 0.005), blood urea nitrogen (r = 0.429, P < 0.05), creatinine (r = 0.490, P = 0.021), and total protein (r = 0.737, P < 0.0001) levels, which all tend to increase as a result of increasing adiposity.
CONCLUSION: Supplementing body fat percentage with five-point BCS appears to increase the likelihood of validating overweight status in small-medium sized dog breeds by detecting changes in plasma metabolite levels, especially lipids, induced as a result of increasing adiposity.

Entities:  

Keywords:  body condition score; body fat percentage; cholesterol; dog; nonesterified fatty acid; triglycerides

Year:  2012        PMID: 30101086      PMCID: PMC6067608          DOI: 10.2147/VMRR.S34665

Source DB:  PubMed          Journal:  Vet Med (Auckl)        ISSN: 2230-2034


  24 in total

1.  Fat distribution and body weight.

Authors:  G A Bray
Journal:  Obes Res       Date:  1993-05

2.  A simple, reliable tool for owners to assess the body condition of their dog or cat.

Authors:  Alexander J German; Shelley L Holden; Glyn L Moxham; Karen L Holmes; Rachel M Hackett; John M Rawlings
Journal:  J Nutr       Date:  2006-07       Impact factor: 4.798

3.  Use of a bioelectric impedance device in obese and lean healthy dogs to estimate body fat percentage.

Authors:  Richard Stone; Nora Berghoff; Jorg Steiner; Deb Zoran
Journal:  Vet Ther       Date:  2009 Spring-Summer

4.  Evaluation of a nine-point body condition scoring system in physically inactive pet cats.

Authors:  Charlotte R Bjornvad; Dorte H Nielsen; P Jane Armstrong; Fintan McEvoy; Kirsten M Hoelmkjaer; Kathrine S Jensen; Gitte F Pedersen; Annemarie T Kristensen
Journal:  Am J Vet Res       Date:  2011-04       Impact factor: 1.156

5.  Companion Animals Symposium: Obesity in dogs and cats: What is wrong with being fat?

Authors:  D P Laflamme
Journal:  J Anim Sci       Date:  2011-10-07       Impact factor: 3.159

6.  Adiposity and adiponectin in dogs: investigation of causes of discrepant results between two studies.

Authors:  K R Verkest; F J Rose; L M Fleeman; J S Rand; J M Morton; A A Richards; K Ishioka; J P Whitehead
Journal:  Domest Anim Endocrinol       Date:  2011-04-30       Impact factor: 2.290

7.  Distinct adiponectin profiles might contribute to differences in susceptibility to type 2 diabetes in dogs and humans.

Authors:  K R Verkest; J S Rand; L M Fleeman; J M Morton; A A Richards; F J Rose; J P Whitehead
Journal:  Domest Anim Endocrinol       Date:  2011-04-30       Impact factor: 2.290

Review 8.  The potential role of leptin and adiponectin in obesity: a comparative review.

Authors:  Rebecca Ricci; Francesca Bevilacqua
Journal:  Vet J       Date:  2011-05-17       Impact factor: 2.688

9.  Effect of breed on body composition and comparison between various methods to estimate body composition in dogs.

Authors:  I Jeusette; D Greco; F Aquino; J Detilleux; M Peterson; V Romano; C Torre
Journal:  Res Vet Sci       Date:  2009-08-18       Impact factor: 2.534

10.  Serum lipid and lipoprotein concentrations in obese dogs.

Authors:  T Chikamune; H Katamoto; F Ohashi; Y Shimada
Journal:  J Vet Med Sci       Date:  1995-08       Impact factor: 1.267

View more
  3 in total

1.  Influence of a Polyherbal Choline Source in Dogs: Body Weight Changes, Blood Metabolites, and Gene Expression.

Authors:  Germán David Mendoza-Martínez; Pedro Abel Hernández-García; Fernando Xicoténcatl Plata-Pérez; José Antonio Martínez-García; Augusto Cesar Lizarazo-Chaparro; Ismael Martínez-Cortes; Marcia Campillo-Navarro; Héctor Aarón Lee-Rangel; María Eugenia De la Torre-Hernández; Adrian Gloria-Trujillo
Journal:  Animals (Basel)       Date:  2022-05-20       Impact factor: 3.231

2.  In vivo assessment of subcutaneous fat in dogs by real-time ultrasonography and image analysis.

Authors:  Rita Payan-Carreira; Luis Martins; Sónia Miranda; Pedro Olivério; Severiano R Silva
Journal:  Acta Vet Scand       Date:  2016-10-20       Impact factor: 1.695

3.  Using bioelectrical impedance analysis for modeling regression and predicting body fat accumulation in dogs in East Thailand.

Authors:  Peera Arreesrisom; Thanmaporn Phichitrasilp; Nattakarn Naimon; Supochana Charoensin; Worawut Rerkamnuaychoke; Jumrueang Panpiansil; Thitichai Jarudecha
Journal:  Vet World       Date:  2022-06-28
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.